Publication: Update on biologic safety for patients with psoriasis during pregnancy
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Porter, Martina L., Stephen J. Lockwood, and Alexa B. Kimball. 2016. “Update on biologic safety for patients with psoriasis during pregnancy.” International Journal of Women's Dermatology 3 (1): 21-25. doi:10.1016/j.ijwd.2016.12.003. http://dx.doi.org/10.1016/j.ijwd.2016.12.003.
Research Data
Abstract
Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating.
Description
Other Available Sources
Keywords
psoriasis, pregnancy, lactation, biologic agents, TNF-alpha inhibitors
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service